Keywords
How to Cite
Abstract
The positive result of chemotherapy for cancer is an increase of the duration of remission and the life of treated patients. However against this background negative secondary effects of chemotherapy began to appear as well. These effects reduce the quality of life of treated patients. These include ophthalmic complications. The review provides clinical data on ophthalmic toxicity of 7 representatives of alkylating compounds and interferon used in chemotherapy. Much attention in the review is paid to retinotoxic effects of these drugs. The mechanism of their geno- and cytotoxic effects and also the role of participants of excision repair in this - N-alkyl-adenine-DNA-glycosylase and poly(ADP-ribose)-polymerase (PARP1) - are considered.
References
Абрамов М.Е., Гуторов С.Л., Славина Е.Г Химиотерапия диссеминированной меланомы кожи с включением ингарона (у-ИФН) // российский биотерапевтический журнал. - 2009. - № 1 (8). - C. 64-74.
Логинова М.Ю., Тронов В.А., Белецкая Т.А. и др. радиорезистентность сетчатки: под действием у-излучения в сетчатке мышей формируются разрывы ДНК, увеличивается содержание белка р53, сопровождаемые репарацией ДНК и отсутствием апоптоза клеток // радиационная биология. радиоэкология. - 2008. - № 6 (48). - C. 698-704.
Островская Л.А., Филов В.А., Ивин Б.А., и др. Препараты класса нитрозоалкилмочевин в отечественной противоопухолевой химиотерапии // рос. биотер. журн. - 2004. - № 1 (3). - C. 24-13.
Abramson D.H., Dunkel I.J., Brodie S.E. et al. A phase I/ II study of direct intraarterial (ophthalmic artery) chemo therapy with melphalan for intraocular retinoblastoma initial results // Ophthalmology. - 2008. - № 8 (115). - P. 1398-1404.
Adhikari S., Toretsky J.A., Yuan L., Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase // The Journal of biological chemistry. - 2006. - № 40 (281). - P. 29525-32.
Agarwal S., Ray B., Mehrotra R. SERS as an advanced tool for investigating chloroethyl nitrosourea derivatives complexation with DNA // International journal of biological macromolecules. - 2015. - № 81. - P. 891-7.
Agnihotri S., Gajadhar A.S., Ternamian C. et al. Alkylpurine- DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients // The Journal of clinical investigation. - 2012. - № 1 (122). - P. 253-266.
Ahel D., Horejs Z., Wiechens N. et al. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1 // Science (New York, NY). - 2009. - № 5945 (325). - P. 1240-3.
Allocca M., Corrigan J.J., Fake K.R. et al. PARP inhibitors protect against sex- and AAG-dependent alkylation-induced neural degeneration // Oncotarget. - 2017. - № 40 (8). - P. 68707-68720.
Anders C.K., Winer E.P., Ford J.M. et al. Poly(ADP-Ribose) polymerase inhibition: «targeted» therapy for triple-negative breast cancer // Clinical cancer research: an official journal of the American Association for Cancer Research. - 2010. - № 19 (16). - P. 4702-10.
Bignami M., O'Driscoll M., Aquilina G., Karran P. Unmasking a killer: DNA O(6)-methylguanine and the cytotoxicity of methylating agents // Mutation research. - 2000. - № 2-3 (462). - P. 71-82.
Boeck K., Hofmann S., Klopfer M. et al. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature // The British journal of dermatology. -1997. - № 3 (137). - P. 457-60.
Boiteux S., Guillet M. Abasic sites in DNA: repair and biological consequences in Saccharomyces cerevisiae // DNA repair. - 2004. - № 1 (3). - P. 1-12.
Cao W., Tombran-Tink J., Elias R. et al. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor // Investigative ophthalmology & visual science. - 2001. - № 7 (42). - P. 1646-52.
Chamberlain M.C. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas // Expert review of neurotherapeutics. - 2010. - № 10 (10). - P. 1537-44.
Chauveinc L., Sola-Martinez M.T, Martin-Duverneuil M. et al. Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas // Journal of neuro-oncology. - 1996. - № 2 (27). - P. 141-147.
Chen C., Damek D., Gaspar L.E. et al. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme // International journal of radiation oncology, biology, physics. -2011. - № 4 (81). - P. 1066-74.
Cohen S.-Y, Bourgeois H., Corbe C. et al. Randomized clinical trial France DMLA2: effect of trimetazidine on exudative and nonexudative age-relatedmacular degeneration // Retina (Philadelphia, Pa.). - 2012. - № 4 (32). - P. 834-43.
Crosbie P.A.J., Watson A.J., Agius R. et al. Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer // Mutation research. - 2012. - № 1-2 (732). - P. 43-46.
Curtin N.J., szabo C. therapeutic applications of PARP inhibitors: anticancer therapy and beyond // Molecular aspects of medicine. - 2013. - № 6 (34). - P. 1217-1256.
Darkes M.J.M., Plosker G.L., Jarvis B. Temozolomide: A Review of its Use in the treatment of Malignant Gliomas, Malignant Melanoma and Other Advanced Cancers // American Journal of Cancer. - 2002. - № 1 (1). - P. 55-80.
Davar D., Tarhini A.A., Kirkwood J.M. Adjuvant therapy for melanoma // Cancer journal. - 2012. - № 2 (18). - P. 192-202.
Dixon M., Woodrick J., Gupta s. et al. Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease // Bioorganic & medicinal chemistry. - 2015. - № 5 (23). - P. 1102-1111.
Eguchi Y, shimizu S., Tsujimoto Y Intracellular ATP levels determine cell death fate by apoptosis or necrosis // Cancer research. - 1997. - № 10 (57). - P. 1835-40.
Ensminger M., Iloff L., Ebel C. et al. DNA breaks and chromosomal aberrations arise when replication meets base excision repair // the Journal of cell biology. - 2014. - № 1 (206). - P. 29-43.
Faustino-Rocha A.I., Ferreira R., Oliveira P.A. et al. N-Methyl-N-nitrosourea as a mammary carcinogenic agent // tumour biology: the journal of the International society for Oncodevelopmental Biology and Medicine. - 2015. - № 12 (36). - P. 9095-117.
Francis J.H., schaiquevich P., Buitrago E. et al. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study // Ophthalmology. - 2014. - № 9 (121). - P. 1810-7.
Ghassemi F., shields C.L. Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma // Archives of ophthalmology (Chicago, Ill.: 1960). - 2012. - № 10 (130). - P. 1268-71.
Gonzaga P.E., Potter P.M., Niu T.Q. et al. Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA // Cancer research. - 1992. - № 21 (52). - P. 6052-6058.
Greenberg H.S., Ensminger W.D., Chandler W.F. et al. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system // Journal of neurosurgery. - 1984. - № 3 (61). - P. 423-9.
Grimson B.S., Mahaley M.S., Dubey H.D., Dudka L. Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine) // Journal of clinical neuro-ophthalmology. - 1981. - № 4 (1). - P. 261-4.
Ha C.S., Michalek J.E., Elledge R. et al. p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study // Molecular oncology. - 2016. - № 1 (10). - P. 148-56.
Hayasaka S., Nagaki Y., Matsumoto M., sato s. Interferon associated retinopathy // Br. J. Ophthalmol. - 1998. - № 3 (82). - P. 323-325.
Hejny C., sternberg P., Lawson D.H. et al. Retinopathy associated with high-dose interferon alfa-2b therapy // American journal of ophthalmology. - 2001. - № 6 (131). - P. 782-7.
Hofseth L.J., Khan M.A., Ambrose M. et al. The adaptive imbalance in base excision-repair enzymes gener ates microsatellite instability in chronic inflammation // the Journal of clinical investigation. - 2003. - № 12 (112). - P. 1887-94.
Hu J., Guo X., Yang L. Morin inhibits proliferation and self-renewal of CD133 melanoma cells by upregulating miR-216a // Journal of pharmacological sciences. -2018.
Imperia P.S., Lazarus H.M., Lass J.H. Ocular complications of systemic cancer chemotherapy // survey of Ophthalmology. - 1989. - № 3 (34). - P. 209-230.
Khawly J.A., Rubin P., Petros W. et al. Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer // Ophthalmology. - 1996. - № 1 (103). - P. 87-95.
Kisby G.E., Lesselroth H., Olivas A. et al. Role of nucleotide-and base-excision repair in genotoxin-induced neuronal cell death // DNA repair. - 2004. - № 6 (3). - P. 617-627.
Kupersmith M.J., Frohman L.P., Choi I.S. et al. Visual system toxicity following intra-arterial chemotherapy // Neurology. - 1988. - № 2 (38). - P. 284-9.
Kupersmith M.J., Teiple W.H., Holopigian K. et al. Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine // American journal of ophthalmology. - 1992. - № 4 (113). - P. 435-8.
Lheureux S., Bruce J.P., Burnier J. V et al. somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition // Journal of clinical oncology. - 2017. - № 11 (35). - P. 1240-1249.
Lin F-L., Lin C.-H., Ho J.-D. et al. The natural retinopro-tectant chrysophanol attenuated photoreceptor cell apop-tosis in an N-methyl-N-nitrosourea-induced mouse model of retinal degenaration // scientific reports. - 2017. - № 7. - P. 41086.
Ma Z., Wei Q., Dong G. et al. DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cells // Biochimica et biophysica acta. - 2014. - № 7 (1842). - P. 1088-96.
Martin D.S., Schwartz G.K. Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade // Oncology research. - 1997. - № 1 (9). - P. 1-5.
Matus G., Dicato M., Focan C. Cancer associated retinopathy (CAR). Two clinical cases and review of the literature // Revue medicale de Liege. - 2007. - № 3 (62). - P. 166-9.
Meira L.B., Moroski-Erkul C.A., Green S.L. et al. Aag-ini-tiated base excision repair drives alkylation-induced retinal degeneration in mice // Proceedings of the National Academy of sciences of the United states of America. - 2009. - № 3 (106). - P. 888-893.
Mocellin S., Pasquali S., Rossi C.R., Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis // Journal of the National Cancer Institute. - 2010. - № 7 (102). - P. 493-501.
Monzon J.G., Hammad N., Stevens S.D., Dancey J. Retinopathy associated with adjuvant high-dose interferon-a2b in a patient with resected melanoma: a case report and review of the literature // The oncologist. - 2012. - № 3 (17). - P. 384-7.
Ockenfels M., Lisch W. Ocular complications of adjuvant interferon therapy for malignant melanoma: a review // Hautarzt. - 2003. - № 2 (54). - P. 144-7.
Pabla N., Huang S., Mi Q.-s. et al. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis // The Journal of biological chemistry. -2008. - № 10 (283). - P. 6572-6583.
Pföhler C., Haus A., Palmowski A. et al. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma // The British journal of dermatology. - 2003. - № 1 (149). - P. 74-78.
Reid J.M., Kuffel M.J., Miller J.K. et al. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1 // Clinical cancer research: an official journal of the American Association for Cancer Research. - 1999. - № 8 (5). - P. 2192-7.
Robins P., Harris A.L., Goldsmith I., Lindahl T. Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase // Nucleic acids research. - 1983. - № 22 (11). - P. 7743-58.
Rottenberg S., Jaspers J.E., Kersbergen A. et al. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs // Proceedings of the National Academy of Sciences of the United States of America. -2008. - № 44 (105). - P. 17079-84.
Saito Т., Yokoyame М., Himori Т. et al. Phase I and preliminary phase II study of l-(4-amino-2-methyl-5-pyrimidinyl)methyl 3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) administered by intermittent dose schedule // Japanese Journal of Cancer and Chemotherapy. - 1977. - № 4. - P. 991-1004
Sato K., Kitajima Y, Koga Y et al. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells // Anticancer research. - 2005. -№6B (25). - P. 4021-8
Schreiber S., Prox-Vagedes V., Elolf E. et al. Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report // BMC cancer. - 2010. - №10. - P. 520
Shimamura Y., Chikama M., Tanimoto T. et al. Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case report // Journal of Neurosurgery. - 1990. - № 2 (72). - P. 285-288.
Shingleton B.J., Bienfang D.C., Albert D.M. et al. Ocular toxicity associated with high-dose carmustine // Archives of ophthalmology (Chicago, Ill.: 1960). - 1982. - № 11 (100). -P. 1766-72.
Smith S.J., Smith B.D. Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review // The British journal of ophthalmology. - 2013. - № 10 (97). - P. 1231-6.
Sobol R.W., Kartalou M., Almeida K.H. et al. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses // The Journal of biological chemistry. -2003. - № 41 (278). - P. 39951-9.
Sobol R.W., Prasad R., Evenski A. et al. The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity // Nature. - 2000. - № 6788 (405). - P. 807-810.
Stoffelns B.M. Interferon causes ischemic ocular diseases -case studies and review of the literature // Klinische Monatsblatter fur Augenheilkunde. - 2006. - № 5 (223).- P. 367-71.
Struwe M., Greulich K.-O., Junker U. et al. Detection of photogenotoxicity in skin and eye in rat with the photo comet assay // Photochem Photobiol. Sci. - 2008. - № 2 (7). - P. 240-9.
Treudler R., Georgieva J., Geilen C.C., Orfanos C.E. Dacarbazine but not temozolomide induces phototoxic dermatitis in patients with malignant melanoma // Journal of the American Academy of Dermatology. - 2004. - № 5 (50). - P. 783-5.
Tsubura A., Lai Y-C., Miki H. et al. Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials // In vivo. - 2011. - № 1 (25). - P. 11-22.
Wang Y., Chen X., Zhang Z. et al. Comparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastoma // Neurosurgical review. - 2014. - № 1 (37). - P. 73-78.
Wilczek Z.M. Experimental intraocular penetration of dacarbazine // American journal of ophthalmology. - 1977. - № 3 (84). - P. 299-304.
Woodhouse B.C., Dianova I.I., Parsons J.L., Dianov G.L. Poly(ADP-ribose) polymerase-1 modulates DNA repair capacity and prevents formation of DNA double strand breaks // DNA repair. - 2008. - № 6 (7). - P. 932-940.
Xu J., Li L., Xiong J. et al. Cyclophosphamide Combined with Bone Marrow Mesenchymal Stromal Cells Protects against Bleomycin-induced Lung Fibrosis in Mice // Annals of clinical and laboratory science. - 2015. - № 3 (45). - P. 292-300.
Ying W., Sevigny M.B., Chen Y, Swanson R.A. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death // Proceedings of the National Academy of Sciences of the United States of America. - 2001. - № 21 (98). - P. 12227-32.
Yoshizawa K., Sasaki T, Uehara N. et al. N -ethyl- N -nitrosourea induces retinal photoreceptor damage in adult rats // Journal of toxicologic pathology. - 2012. - № 1 (25). - P. 27-35.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018